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Introduction
Vitamin D₃ is a fat soluble vitamin, stored mainly in the liver 
and adipose tissue. It is primarily obtained by the conversion of 
cutaneous 7-dehydrocholesterol to previtamin D₃ by sunlight, 
specifically Ultraviolet (UV) B radiation with a wavelength of 
290–320 nanometers. Previtamin D₃ then spontaneously isom-
erizes to vitamin D₃, or cholecalciferol. Vitamin D3 is biologically 
inert and must undergo two hydroxylation to be biologically 
active. The first hydroxylation occurs in the liver, by 25-hydrox-
ylase, converting vitamin D3 to calcidiol, or 25-hydroxyvitamin 
D [25(OH)D]. The second hydroxylation occurs by 1α-hydrox-
ylase, found primarily in the kidneys, although recent research 
found this enzyme in many other tissues. The second hydrox-
ylation converts the 25-hydroxyvitamin D to the biological-
ly-useful calcitriol, or 1,25-dihydroxyvitamin D [1,25(OH)2D] 
(Vitamin D: Fact, 2016). 
Besides for obtaining vitamin D by sun exposure, vitamin D can be 
obtained by food. However, very few foods in nature contain vita-
min D. Therefore, a better way of obtaining vitamin D is from chole-
calciferol-fortified foods or supplements (Vitamin D: Fact, 2016). 
Serum concentration of 25-hydroxyvitamin D is the best indica-
tor of vitamin D status, because it reflects vitamin D obtained 
by sun exposure and ingestion. It also has a fairly long circulating 
half-life of 15 days and its concentration is not affected by other 
metabolites. However, it does not indicate how much vitamin 
D is stored in body tissues. In contrast, 1,25-dihydroxyvitamin 
D has a short circulating half-life of 15 hours and its levels are 
closely regulated its own concentration and by hormones and 
electrolytes like parathyroid hormone, calcium, and phosphate. 
Additionally, levels of 1,25(OH)2D only decreases when vitamin 
D deficiency is severe. Therefore, 25-hydroxyvitamin D levels 
are used to assess sufficiency (Vitamin D: Fact, 2016).
There is considerable discussion of what serum concentrations 
of 25-hydroxyvitamin D indicate vitamin D deficiency, adequacy 
for bone health and optimal health overall. As of now, there 
is no specific cut points established by a scientific consensus 
process. However, the committee of the Institute of Medicine, 
based on its review of data of vitamin D needs, have concluded 
that there is a risk of vitamin D deficiency at serum 25(OH)
D levels of less than 30 nmol/L (<12 ng/mL). Additionally, some 
people are potentially at risk for inadequacy at concentrations 
ranging from 30-50 nmol/L (12–20 ng/mL). They stated that 50 
nmol/L is the serum 25-hydroxyvitamin D level that is adequate 
for 97.5% of the population. Only at concentrations of greater 
than 125 nmol/L (>50 ng/mL) is there potential adverse effects 
of overdose (Vitamin D: Fact, 2016).
Cutaneous vitamin D levels are mainly dependent on climate, 
overall skin exposure, skin melanin content and age. Residing 
in a climate closer to the equator results in more year-round 
sun exposure and more vitamin D synthesis. Although surpris-
ingly, geographic location does not consistently predict average 
serum levels in a population. Opportunities exist to form vita-
min D from exposure to sunlight during the spring, summer, and 
fall months even in the far north or south, and it can be stored 
in fat for periods of little sunlight. Darker skin absorbs less 
sunlight and, therefore, more melanin reduces the production 
of vitamin D. Perhaps, this characteristic may contribute to the 
consistency in average serum levels of those near the equator 
and those further away, because those who live near the equa-
tor generally have a darker skin tone that synthesis less vitamin 
D than those farther away with a lighter skin tone.  Vitamin 
D synthesis may also decline with age because skin synthesis 
declines (Johnson, 2016). 
Major depressive disorder (MDD) is a common disorder and 
leading source of disability worldwide. It is a major global health 
problem, with more than 50% of all suicides contributed to 
clinical depression (Bay-Richter, Janelidze, Hallberg, & Brundin, 
2011). Classically, the prevailing hypothesis on the cause of major 
depression was a deficiency of monoamines, a class of neu-
rotransmitters and neuromodulators, like serotonin. Therefore, 
current available medications for major depression mainly tar-
get monoamine pathways. However, research has not shown 
a consistent relationship between serotonin and depression 
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(Gardner & Boles, 2011). And although relatively affective, 30% 
of depressed patients do not achieve remission even with mul-
tiple, monoamine-regulating, treatment trials (Miller, Maletic, & 
Raison, 2009). Additionally, 50% to 80% of all patients treated for 
major depression will experience relapse (Bay-Richter, Janelidze, 
Hallberg, & Brundin, 2011). These monoamine regulating drugs 
can have serious side effects, which include worsening of depres-
sive symptoms and suicidal ideation. Therefore, it is imperative 
to find novel pathways involved in depression and consequently 
more effective treatments for those suffering.
Historically, in literature, and in art and religion, happiness and 
positivity have been associated with summertime, daylight, and 
sunny and open landscapes. In contrast, fear and gloom have 
been associated with winter, night and dark and polluted ur-
banscapes. At the height of early industrialism, in such polluted 
cities, rickets, which is extreme vitamin D deficiency was first 
recognized. Among the symptoms of rickets, mental symptoms 
were also described and Florence Nightingale stated: “People 
say the effect [of sunlight] is on the mind. So it is, but the enlight-
ened physician tells us it is on the body too.” (Humble, 2010) 
Mental disturbances caused by reduced sun exposure seemed 
self-evident that no one seemed to note the mental health ben-
efits of rickets treatment, which was primarily to increase sun 
exposure. Because of the awareness of adequate sun exposure, 
rickets disappeared as a public health problem. Nevertheless, 
from the 1950s and on, with increasing modernization, the time 
spent indoors increased for all ages worldwide. Additionally, 
since the 1980s, the public is being warned about the dangers of 
UV rays and its contribution to malignant melanoma. Therefore, 
people have developed concern of excessive sun exposure and 
are applying sunscreen and covering up more when they are 
outside. At the same time, as these changes are taking place, the 
incidence of depression, especially in children and adolescents, 
has become more and more prevalent in the United State and 
Europe (Humble, 2010). Additionally, it is a long, well-known and 
perplexing observation that death by suicide is highest in the 
springtime for people living in temperate climates, which is also 
when vitamin D levels are the lowest in the population (Umhau 
et al., 2013). Is there a correlation between these two observed 
phenomena of depression and vitamin D synthesis, and what 
would be there relationship?
Materials and Methods
Materials for this comprehensive review were obtained from 
Touro College’s online library, PubMed, PubMed central, 
Proquest, National Institute of Health website and Merck 
Manual website. The material consisted of clinical research pa-
pers, peer-reviewed journal articles and clinician-directed infor-
mational reports. The material was reviewed, critically analyzed 
and compiled to answer research questions.
Discussion
Vitamin D and Inflammation:
Classically, Vitamin D is associated with bone health. Vitamin 
D aids calcium absorption in the gut and maintains adequate 
serum calcium and phosphate levels for normal mineralization 
of bone (Vitamin D: Fact, 2016). It is also needed by osteoblasts 
and osteoclasts bone growth and repair. Vitamin D deficiency 
was mostly associated with rickets and osteomalacia at extreme 
deficiency. Rickets is a disease in children where vitamin D de-
ficiency leads to bones not being able to properly mineralize, 
which results in soft bones and skeletal deformities. In adults, 
vitamin D deficiency can lead to osteomalacia, or weak bones 
(Vitamin D: Fact, 2016).
Recently, many other functions of vitamin D have been discov-
ered and vitamin D receptors have been found in many tissues. 
One of the most significant findings is the function of vitamin 
D in immune system modulation. There is an increasing num-
ber of studies that demonstrate the importance of vitamin D in 
the reduction of inflammation and the association of vitamin D 
deficiency with increased inflammation (Peterson & Heffernan, 
2008). Most of the known effects of vitamin D are facilitated 
through vitamin D receptors (VDR). These vitamin D receptors 
have been found extensively in immune system cells, specifically 
in T lymphocytes and macrophages. Furthermore, macrophages 
have been found to express 1α-hydroxylase, which is the en-
zyme that is responsible for the final step in synthesizing bio-
logically-active vitamin D. Additionally, they have been found to 
express 24-hydroxylase, the major degrading enzyme of vita-
min D. This means that these cells can regulate the production 
and secretion of vitamin D in their own vicinity (Peterson & 
Heffernan, 2008).
Additional evidence now suggests that vitamin D insufficiency 
may play a role in immune system dysfunction and low 25-hy-
droxyvitamin D serum levels are shown to be associated with 
autoimmune diseases like multiple sclerosis, Type 1 diabetes 
and rheumatoid arthritis. Recently, this insufficiency has been 
correlated to macrophage dysfunction, such as impaired che-
motaxis, phagocytosis and increased production of proinflam-
matory cytokines. Proinflammatory cytokines are produced 
predominantly by activated macrophages. These cytokines take 
part in cell signaling and up-regulation of inflammatory reac-
tions. Vitamin D has been shown to reduce inflammation by 
down-regulating the expression of monocyte toll-like receptors 
(TLRs), which are known to activate inflammation and aggravate 
autoimmune disease and sepsis (Peterson & Heffernan, 2008).
In light of the research, Peterson and Heffernan (2008) sought 
to investigate the relationship between serum vitamin D status 
(25(OH)D) and inflammatory markers in 69 healthy women. 
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They recruited people with high UVB and minimal UVB ex-
posure, as assessed by a screening questionnaire, to obtain a 
range of serum levels. Volunteers were excluded for multiple 
factors, including, if they took a vitamin D supplement, had a 
current or previous medical condition or took medication af-
fected immune function. The results revealed that serum TNF-
α, a proinflammatory cytokine, was significantly lower in the 
group of women with high UVB exposure, after controlling for 
multiple factors. However, there was no significant statistical 
difference shown between the two groups in regards to other 
proinflammatory cytokines, like IL-10, CRP, IL-6. Serum TNF-α 
concentrations are increased in several diseases like multiple 
sclerosis, inflammatory bowel disease, rheumatoid arthritis, 
heart disease and osteoporosis, and lowering TNF-α concen-
trations through sufficient vitamin D levels may improve disease 
outcomes. The main limitation of this study was the small sam-
ple size. Additionally, women who frequently tan are character-
istically different from non-tanners and may engage in behaviors 
that can affect the study outcomes. This study shows a negative 
correlation between vitamin D status and TNF-α concentration 
in healthy individuals. More research is needed to determine if 
vitamin D can be used as a therapy in inflammatory diseases.
A case where vitamin D deficiency seems to contribute to 
immune modulation, is in diabetic foot infection. Diabetic foot 
infection is a reflection of a diabetic patient’s altered immune 
system. In an infectious state, pro-inflammatory cytokines are 
released in the body, such as IL-1β, IL-6, interferon-γ (IFN-γ) 
and TNF-α, or chemokines such as IL-8. To counteract these 
factors and avoid a hyper-inflammatory state, the body releases 
anti-inflammatory cytokines such as IL-10. In a diabetic patient, 
several factors lead to decreased wound-healing abilities, includ-
ing impaired cytokine production. This abnormal wound healing 
is attributed to immune dysregulation because of vitamin D de-
ficiency in addition to hyperglycemia (Timms et al., 2002).
Another study, investigating the relationship between vitamin D 
deficiency and increased inflammatory cytokines, was done by 
Timms et al. (2002), by evaluating the influence of vitamin D on 
the concentrations of IL-1β, TNF-α, IFN-γ and IL-6 in patients 
with diabetic foot infection. Subjects were 112 diabetic patients 
with diabetic foot infection while 107 diabetic patients with no 
evidence of infection served as controls, additionally, 40 healthy 
subjects were included in the study. Vitamin D deficiency, a 
serum 25-hydroxyvitamin D < 50 nmol/l, was found in 71.4% of 
the diabetic foot infection patients, 61.6% of the diabetic con-
trols and 48.6% of the healthy volunteers, but severe deficiency, 
with a serum 25-hydroxyvitamin D of < 25 nmol/L, was mostly 
found in diabetic foot infection patients than in diabetic controls 
and healthy volunteers. In both patients and controls, 25-hy-
droxyvitamin D levels was found to be significantly negatively 
correlated with IL-1β as well as IL-6 levels and moderately neg-
atively correlated with TNF-α levels, but not correlated with 
IFN-γ levels. In this study, diabetic patients with foot infection 
serve as a model for immune system abnormality resulting from 
hyperglycemia and infection, with increased pro-inflammato-
ry cytokine concentrations. The results of the present study 
showed that elevated cytokine responses occur as a factor of 
vitamin D deficiency in patients with diabetic foot infection. 
Vitamin D deficiency, particularly when serum levels were very 
low, intensified inflammatory cytokine release in patients with 
diabetic foot infection.
Because of this increasingly strong correlation and possibly 
causation of vitamin D deficiency to amplified inflammation, and 
to try to prove causation more visibly, Hoe et al. (2016) recently 
performed a study ex vivo. They studied the effects of 1,25-di-
hydroxyvitamin D, the active metabolite of vitamin D, on pe-
ripheral blood mononuclear cells (PBMCs) and purified immune 
cell subsets isolated from healthy patients, when they exposed 
those cells to stimulation with Gram-positive heat-killed pneu-
mococcal serotype 19F (HK19F) and Gram-negative Escherichia 
Coli serotype 055:B5 derived lipopolysaccharide (LPS) bacterial 
ligands. They found that in 1,25(OH)2D3 pretreated samples 
compared to non-treated, for both ligands, 1,25(OH)2D3 
suppressed proinflammatory cytokines, like TNF-α, IFN-γ and 
IL-1β, and chemokine IL-8, in peripheral blood mononuclear 
cells (PBMCs) and TNF-α and IL-1β in CD14+ Monocytes. 
Anti-inflammatory IL-10 was increased in HK19F-stimulated 
monocytes. Additionally, when comparing the blood samples of 
the healthy subjects, they found that levels of HK19F-specific 
IFN-γ were significantly higher in vitamin D-insufficient adults 
(<50 nmol/L) compared to sufficient adults (>50 nmol/L). This 
study suggests Vitamin D causes modulation of inflammation of 
the immune system response which is critical for host defense.
Inflammation and Depression
The progression and complications of many diseases and disor-
ders, like cardiovascular disease, diabetes and cancer, are being 
increasingly attributed to inflammatory dysfunction. Additionally, 
this theory of disorder is being extended to neuropsychiatric 
disorders, with mounting evidence suggesting that defective al-
terations of the immune system seen in psychiatric patients may 
contribute to their disorders, and with mounting evidence of 
inflammation contributing to major depressive disorder. Patients 
with major depression have been found to exhibit elevated 
proinflammatory cytokines, like IL-1β, TNF-α and IL-6, which 
have been shown to interact with areas known to be involved 
in depression, including neurotransmitter metabolism, neuroen-
docrine function, and neural plasticity. Furthermore, psychosocial 
stress, a common precipitator to major depression, has been 
shown to have the ability to stimulate inflammation, owing to 
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the fact that it activates sympathetic nervous system pathways. 
Moreover, depressed patients with increased inflammatory mark-
ers have been found to have greater resistance to treatments, and 
in studies, antidepressant drugs have been found to be correlated 
with decreased inflammation (Miller, Maletic, & Raison, 2009). 
Recurrent coinciding comorbidities and drug efficacies suggest 
that depression is part of a group of related conditions, all of 
which are associated with inflammation dysfunction. They are 
sometimes referred to as the “affective spectrum disorders”, 
and include migraine, irritable bowel syndrome, chronic fatigue 
syndrome, fibromyalgia and generalized anxiety disorder, among 
many others. Based on current knowledge, these diseases, in-
cluding depression, seem to be a function of three connected 
abnormalities: monoamine dysfunction, increased inflammation, 
and mitochondrial disorder (Gardner & Boles, 2011)
To test if inflammation may correlate or even cause major 
depression, several studies performed on animals who have 
been injected with the endotoxin lipopolysaccharide (LPS) to 
generate inflammation, showed that these subjects subsequent-
ly developed depressive-like symptoms. In clinical practice, it 
has been seen that patients treated with interferons and in-
terleukins, to promote inflammation against certain forms of 
cancer and viral infections, like Hepatitis C, frequently develop 
depression. To further investigate this relationship Bay-Richter, 
Janelidze, Hallberg, & Brundin (2011) induced inflammation in 
rats by administering Escherichia coli serotype 055:B5 lipopoly-
saccharides (LPS) intraperitoneally for four days. They measured 
their levels of cytokine markers at the state of sickness and 
then at the state of depressive-like behaviors. They also mea-
sured mRNA transcription of cytokines in specific brain areas 
related to depression as well as levels of cytokines in serum 
and cerebral spinal fluid. Cyclooxygenase enzymes, inflammato-
ry stimulating COX-1 and COX-2, have previously been shown 
to correlate with depressive-like behavior, thus, it is suggested 
that proinflammatory cytokines can induce depressive-like be-
havior by activating prostaglandins, and inflammation, through 
the cyclooxygenase enzyme. Therefore, they also measured cy-
clooxygenase enzymes in the brain of the mice. This is the first 
published study examining the relationship between proinflam-
matory cytokines and cyclooxygenase enzymes in the blood, 
CSF and depression-related brain areas and their capacity to 
cause sickness and behavioral changes.
In this study, they found that there was a clear distinction be-
tween the phase of sickness, which is 2 hours after injection 
of lipopolysaccharides, and the phase of depressive symptoms, 
which is 24 hours after injection, for cytokines, cyclooxygenase 
enzymes and mRNA transcription of cytokines. During the sick-
ness behavior, IL-1β and IL-6 were elevated in the blood, IL-1β 
was elevated in the CSF, and TNF-α was elevated in the striatum 
of the brain. Also, IL-1β mRNA transcript was increased in the 
frontal cortex and hippocampus. Curiously, in this phase, IL-6 
and COX enzymes were decreased in the hippocampus. After 
24 hours of injection, the rats did not show signs of sickness but 
began displaying depressive symptoms in the forced swim test. 
This test is used on rodents to evaluate depression and is used 
when assessing antidepressant drugs and therapies.  During the 
depressive phase of behaviors, the transcription of TNF-α mRNA, 
IL-6 levels and COX enzymes levels shifted back to normal lev-
els in all brain areas, but the cytokine IL-1β was still significantly 
elevated in the frontal cortex and hippocampus and there was 
an increase in the concentration of IL-1β in the cerebral spinal 
fluid. This increase was only found in the CSF and not in blood 
serum. This may explain why studies measuring the serum level of 
cytokines in patients with major depressive disorder, did not find 
any significant difference when comparing depression levels with 
normal levels. In this study, they found that Lipopolysaccharide-
induced depression is primarily associated with the increase of 
IL-1β. This cytokine remains elevated in the brain even after the 
initial inflammatory phase and continues to contribute to a de-
pressive-like phenotype in the rats. This suggests that a short term 
immune inflammatory response may lead to long term changes 
in transcription of inflammatory markers and that transcription 
levels may even increase after the initial immune response (Bay-
Richter, Janelidze, Hallberg, & Brundin, 2011).
Although, elevated inflammatory markers are found in many pa-
tients with psychiatric disorders, there is no clear differentiation 
or explanation why some patients have elevated cytokine concen-
trations and some do not. Perhaps, there is a specific subgroup 
of patients that will display signs of inflammation. To advance and 
investigate if the phenomenon of increase cytokine concentra-
tions in psychiatric patients is specific to a subgroup of depressed 
patients, Janelidze, Mattei, Westrin, Traskman-Bendz, & Brundin 
(2011) designed a study dividing their subjects by non-suicidal 
and suicidal patients. In this study, they compared plasma cytokine 
levels in 47 treated and untreated patients with depression that 
had attempted suicide, 17 untreated patients with a diagnosis of 
major depressive disorder that did not have any suicidal ideation 
and 16 somatically healthy controls with no current or previous 
history of neuropsychiatric disorder. They found statistically sig-
nificant elevated plasma concentration of proinflammatory cyto-
kines IL-6 and TNF-α and decreased plasma concentrations of 
anti-inflammatory cytokine IL-2 in the suicide attempters, com-
pared to the non-suicidal depressed patients and healthy con-
trols. Elevated cytokines were seen in suicidal patients, regardless 
if they had received treatment or not. Although a limitation of 
this study is that the duration of the disorder and duration of 
treatment were not considered. Interestingly, these patients with 
elevated cytokines did not show any signs of systemic or local 
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infection or inflammation. This suggests that inflammation seen in 
depressed patients is specific to those that are suicidal, although 
it may also be specific to different subgroups of depression too. 
Furthermore, it suggests that these elevations are associated 
and may contribute to suicidal ideation. Because this study used 
patients with untreated major depression, one group it did not 
control for specifically, is patients with treatment-resistant de-
pression, and therefore, perhaps increased cytokines is seen in all 
patients with treatment-resistant depression, not only those who 
have attempted suicide. Evidence of abnormal cytokine elevations 
were observed in suicidal patients, compared to non-suicidal 
depressed patients and healthy controls, and may contribute to 
suicidality.
As the mechanism that causes depression and suicide is locat-
ed in the brain, it is important to understand if these systemic 
inflammatory changes relate to changes in the central nervous 
system. Lindqvist et al. (2009) tested the proinflammatory cy-
tokine profile of the cerebral spinal fluid (CSF) of 63 institu-
tionalized patients who had recently attempted suicide com-
pared to healthy controls. They also evaluated if there was a 
difference in the cytokine profile of patients who had attempt a 
violent method of suicide compared to the patients who used 
a nonviolent method. The patients underwent a “wash-out” 
period where they discontinued all antidepressant and antipsy-
chotic medication until there was no trace of it in their blood. 
Depressive symptoms were assessed using the Montgomery-
Åsberg Depression Rating Scale (MADRS) and suicidal ideation 
was assessed using the Suicide Assessment Scale (SUAS). They 
found that the patients who had attempted suicide had higher 
levels of cytokine IL-6 in their cerebral spinal fluid to healthy 
patients, and the violent suicide attempters had the highest con-
centration of IL-6. They also found that CSF IL-6 had a positive 
correlation with intensity of depressive symptoms in all suicid-
al patients. Additionally, they found that IL-6 levels correlated 
positively with current suicidal ideation and suicidal symptoms, 
as in patients expressing a “wish to die” and “preoccupation 
with suicidal thoughts.” These results suggest that, as discussed 
previously, IL-6 may have specific relevance to suicide. They did 
not find any significant difference in proinflammatory cytokine 
IL-1β, TNF-α, and IL-8 between the groups studied. Lindqvist et 
al. then went further to try to determine a mechanism of how 
these abnormalities may contribute to suicidality. They com-
pared levels of cytokines with known biomarkers of depression 
and suicide and found that both IL-6 and TNF-α was related to 
increased levels of 5-HIAA, which is a metabolite of serotonin, 
and HVA, which is a metabolite of dopamine, in the fluid of the 
patients who attempted violent suicide methods. This suggests 
that proinflammatory cytokines may modulate monoamines in 
the central nervous system. Further, longitudinal studies would 
be helpful in studying the effects of cytokine and monoamine 
fluctuation and its neuropsychiatric effects. In summation, 
Lindqvist et al. found that inflammatory cytokines were directly 
correlated with the presence and extent of suicidal thought and 
behavior and the degree of violence of a suicide attempt.
Vitamin D and Depression
As discussed previously, there is strong evidence that vitamin 
D deficiency may be contribute and cause immune system dys-
function, including elevated inflammatory markers. And elevated 
inflammatory markers may play a role in depression with suicid-
al ideation. Therefore, there are many that suggest that vitamin 
D deficiency may be a contributing factor in those who suffer 
from suicidal thoughts accompanying major depressive disorder. 
The presence of vitamin D receptors (VDR), in the central ner-
vous system was first discovered in 1982 by Stumpf, Sar, Clark, 
and DeLuca. And nowadays, there is significant evidence of vi-
tamin D’s presence and actions on different parts of the brain 
and nervous system functioning. There is increasing evidence 
that the vitamin D receptor (VDR) mediates transcription of 
more than 1,000 genes (Umhau et al., 2013). Calcitriol is known 
to function in the regulation of neurotransmitters, specifically 
dopamine, adrenaline, noradrenaline and acetylcholine, regulates 
several neurotrophic factors of the central nervous system, by 
enhancing nerve growth factor (NGF) and glial derived neuro-
trophic factor (GDNF), and assist with anti-oxidative properties 
in the brain (Humble, 2010). Many of the effects that vitamin D 
has on the brain, share pathways with factors, when abnormal, 
are known to be associated with several neuropsychiatric disor-
ders including major depressive disorder (Humble, 2010). Based 
on this, inadequate levels of vitamin D may lead to changes in 
the central nervous system that may interfere with brain func-
tion and contribute to mood disorders.
As depression is underdiagnosed in non-institutionalized healthy 
populations and subclinical depression and chronic low mood is 
common in older adults, and is a factor in morbidity, mortality 
and quality of life, one study seeking to clarify if vitamin D may be 
associated with depression in healthy adults was done by Lee et 
al. (2011). Lee et al. used baseline data from the European Male 
Ageing Study (EMAS), a cohort study of male aging in Europe, to 
determine whether concentrations of serum 25-hydroxyvitamin 
D were associated with levels of depression in a large sample 
size of 3151 subjects, well-characterized, community-dwelling 
sample of middle-aged and older men with a mean age 60 ± 11. 
Subjects were assessed on social issues, lifestyle behaviors, and 
any related comorbidities, like heart conditions, pituitary dis-
ease, diabetes, and cancer. Depressive symptoms were assessed 
using the Beck Depression Inventory-II (BDI-II). Their results 
found that serum vitamin D concentrations were significantly 
lower in men with depressive symptoms, scoring ≥14 on the 
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BDI-II, 10 nmol/L decrease in 25-hydroxyvitamin D was associ-
ated with an average increase of 5.2% in the BDI-II score. Even 
after adjusting for age, smoking, alcohol consumption, physical 
activity, BMI, comorbidities and adverse life events, there was 
still a significant difference in serum vitamin levels. Additional 
adjustment for season did not change this inverse association. 
Only 22 men (0.7%) reported taking vitamin D supplements and 
exclusion of these men did not change the results. A major lim-
itation of this study, is its difficulty in assessing causality or even 
if vitamin D contributes to depression. It may be that vitamin D 
insufficiency may just be a ‘risk marker’ of general poor health 
and lifestyle. Depressive behaviors of decreased physical activity 
and exposure to sunlight may by itself lead to lower vitamin D 
levels. Lee et al. did attempt to adjust for this factor by assessing 
if physical activity can contribute to low vitamin D levels but 
this adjustment does not measure sunlight exposure or rule out 
reverse causality. The main strengths of this study is their large 
sample size of healthy subjects of similar origin and uniform 
methods of assessing depressive symptoms. Their study did find 
an inverse relationship between serum vitamin D levels and de-
pressive symptoms, mostly independent of confounding factors.
To further this relationship and see if low vitamin D levels is a 
conclusively a predisposing factor of suicide, Umhau et al. (2013), 
did a case-control study of 25-hydroxyvitamin D concentration, 
of serum samples stored in the Department of Defense Serum 
Repository, of deployed active-duty service members who had 
subsequently committed suicide. 495 subjects were selected 
from the Armed Forces Health Surveillance Center (AFHSC) 
who had officially verified suicides occurring between 2002 
and 2008 and had blood sampled within 24 months of death. 
Controls were randomly selected from the same data bank, and 
were matched as taking the blood work within 12 months of 
those who had committed suicide, to minimize for any tempo-
ral changes in military environment. They found an increased 
risk of suicide in lower levels of serum 25-hydroxyvitamin D, 
and all those who committed suicide has a seasonally adjusted 
levels below 20 ng/mL. Additionally, they found that 30% of the 
suicides assessed occurred in those in the lowest levels of vita-
min D status. When they graphed the data, they found a curve 
that is characteristic of nutritional intake, which appears to have 
benefit until a threshold is reached and after that, any additional 
enrichment shows little benefit. Meaning, that if sufficient nu-
trient input is reached then further input will have no effect 
on outcomes. Which is important when considering Vitamin 
D supplementation as a treatment method, as discussed later. 
One limitation of this study, is that vitamin D levels were not 
measured at the time of suicide but sometimes months before. 
This problem is lessened by the fact that vitamin D levels are 
shown to be correlated up to 3 years apart. Perhaps, active-du-
ty service members may have a higher risk of suicide because 
they often work at night and are excessively covered up in the 
daytime, therefore, their reduced sun exposure and subsequent 
reduced vitamin D synthesis contributes to their suicidality. In 
this study, vitamin D status before suicide attempt was inversely 
correlated with suicide risk in a large sample size of a specific 
subset of the population with a general high risk of suicide.
 Suicidal ideation may be sudden and in most cases, the first 
thoughts of suicide often occur less than 10 minutes before the 
suicide attempt. In a young, and somewhat aggressive, popula-
tion like military service members, impulsivity may contribute 
to their risk of suicide. There seems to be a link between vita-
min D and impulsivity, as vitamin D increases proinflammatory 
cytokines in the brain. Proinflammatory cytokines reduces se-
rotonin activity which is long associated with impulsive suicide 
(Umhau et al.,2013). As discussed in detail earlier, perhaps, this 
effect of vitamin D is the mechanism by which vitamin D defi-
ciency contributes to higher suicide rates. 
Is present vitamin D concentration associated with suicide at-
tempt? As a similarly designed study discussed previously, done 
by Janelidze, Mattei, Westrin, Traskman-Bendz, & Brundin (2011) 
to show that increased inflammatory cytokine concentration 
of IL-6 and TNF-α contributes to suicide risk, Grudet, Malm, 
Westrin, & Brundin (2014), takes it a step further, to see if vi-
tamin D concentrations, which also contributes to increased 
inflammatory cytokine concentrations, differ in suicidal de-
pressed patients compared to non-suicidal depressed patients. 
They included a total of 59 patients who had attempted suicide, 
and had two control groups of 17 untreated patients with major 
depressive disorder who had no suicidal ideation and 14 somat-
ically and psychiatrically healthy patients. They found a significant 
difference in serum 25-hydroxyvitamin D levels between groups, 
with the suicide attempters have a significantly lower mean vi-
tamin D concentration, of 47 ± 20 nmol/L, than the non-suicidal 
patients, 62 ± 27 nmol/L, and healthy patients, 65 ± 26 nmol/L. 
Additionally, 58% of patients in the suicidal group had a clinical 
vitamin D deficiency of below 50 nmol/L, compared to 30% in 
the other two control groups. When comparing vitamin D levels 
and inflammatory cytokines in all groups, they found a correla-
tion between 25-hydroxyvitamin D serum concentrations and 
proinflammatory cytokine serum concentration of IL-1β. They 
did not find a statistically significant correlation between vitamin 
D and cytokines IL-6 and TNF-α in all groups. When comparing 
individual groups, they found an inverse association between 
25-hydroxyvitamin D and IL-1β in the patients who attempted 
suicide and an inverse association between 25-hydroxyvitamin 
D and IL-6 in the non-suicidal depressed patients. In conclusion, 
they found a negative correlation between vitamin D levels and 
suicide risk and a negative correlation between vitamin D levels 
and proinflammatory cytokines. The cross-sectional design of 
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this study does not allow any conclusions whether low vitamin 
D status can be a direct contributing factor of suicide, but based 
on previous knowledge of the mechanism of 1,25-dihyroxyvita-
min D on brain function and regulation, there is considerable 
evidence to suggest a direct causality.
Vitamin D deficiency is common in the modern world and 
Vitamin D supplementation is relatively inexpensive nutritional 
additive. If this vitamin D insufficiency has a direct contribution 
on depression and suicide, can vitamin D be used a treatment 
to reduce depressive symptoms and stop the epidemic of de-
pression and suicide worldwide?
As a vitamin D intake is an easy nutritional therapy, Bertone-
Johnson et al. (2011) seeks to clarify if vitamin D supplemen-
tation can prevent or treat depression. They patients used for 
this study were part of a large and diverse sample size that 
was tracked for a long period of time. The subjects used for 
this study were part of the observation study (OS) compo-
nent of the Women’s Health Initiative (WHI) This is a database 
composed by the National Institute of Health which allowed 
Bertone-Johnson et al. to follow the health of 81,189 post-
menopausal women over an 8-year period. Baseline intake was 
assessed by asking patients about diet and any vitamin D sup-
plementation and estimates of total solar irradiance was cal-
culated based on the geographic location of the clinic centers 
and controlled when interpreting the results. At each clinic 
visit, depressive symptoms were assessed using the Burnam 
8-item scale for depressive disorders. When controlling for 
confounding factors, they found that lower vitamin D intake 
of <100 IU/day had a strong inverse correlation in women 
who met criteria for prevailing depressive symptoms at the 
baseline visit. And the reverse was also true, those patients 
with a substantial intake of vitamin D was associated with a 
lower prevalence of depressive symptoms. This effect seemed 
to have a threshold, as those positive effects of increased in-
take was only shown in patients who consumed 400 to <800 
IU/day and an intake of ≥800 IU/day was not associated with 
decreased risk of depression. At year 3 of the study increased 
vitamin D intake was correlated with lower risk of depressive 
symptoms in patients with no evidence of depression at base-
line. A limitation of this study, is that it did not measure serum 
25-hydroxyvitamin D levels in conjunction with intake levels. 
This is important as the effects of vitamin D intake on serum 
vitamin D levels may differ in individuals. Individuals may differ 
in the processing of vitamin D ingestion; these differences are 
in part because of genetic factors, vitamin D metabolism and 
general dietary intake. This study saw an inverse relationship 
between vitamin D intake and depressive symptoms in older 
women.
One study, looking at the direct effects of vitamin D supple-
mentation on depressive symptoms in conjunction with meta-
bolic profiles, c-reactive protein (CRP), an inflammatory marker, 
and oxidative stress. Sepehrmanesh et al., (2016) performed a 
randomized, double-blind, clinical trial in performed in Kashan, 
Iran, from October 2014 to December 2014. They included 36 
patients, ages 18–65 years, equal parts men and women, diag-
nosed with major depressive disorder and randomly assigned 
18 of them to receive a single capsule of 50,000 IU vitamin D 
weekly and 18 patients to receive a placebo weekly for 8 weeks 
in total. The Beck Depression Inventory (BDI) was used to as-
sess depressive symptoms before and after supplementation. As 
expected, after 8 weeks, changes in vitamin D concentrations 
were greater in the vitamin D group than in the placebo group. 
The group taking vitamin D supplements had improved insulin 
function and decreased oxidative stress than the patients that 
took a placebo. No changes were seen in c-reactive protein lev-
els between both groups. This may be because of the duration 
of the study or the specific inflammatory marker studied, as dif-
ferent inflammatory markers have been found to be associated 
with vitamin D deficiency and depression. But most importantly, 
this study found that the patients taking vitamin D supplements 
had significant decreased depressive symptoms, and decreased 
BDI total scores, post-nutritional therapy compared to before. 
As all these patients had vitamin D deficiency of less than 20 
μg/L at the start of this study, it is not possible to assess if the 
effects of supplementation are seen only in vitamin D deficient 
individuals or this therapy may also be useful in those who have 
clinically sufficient levels of vitamin D. Perhaps the beneficial ef-
fects of supplementation can be explained by the fact that both 
groups had a low baseline mean serum 25-hydroxyvitamin D 
level. Therefore, a relatively short supplementation period was 
effective in lowering depressive symptoms. Overall, vitamin D 
supplementation had a positive effect on lowering depressive 
symptoms in patients with major depressive disorder. 
Conclusion
Vitamin D status seems to be directly linked to mood disor-
ders and particularly major depression. A mechanism for this 
association is demonstrated in detail, as both are correlated 
to inflammatory cytokine status. Vitamin D deficiency is asso-
ciated with an elevation of proinflammatory cytokines because 
vitamin D modulates and prevents uncontrolled inflammation 
systemically and in the central nervous system. This elevation of 
proinflammatory cytokines may have adverse psychiatric effects. 
It can contribute to depressive symptoms and even suicide. 
Patients with suicidal thoughts specifically, seem to have abnor-
mal proinflammatory cytokines and lower levels of vitamin D in 
their body, than patients with major depression that do not have 
suicidal thoughts.
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As the conceptual understanding of vitamin D’s activity as a 
neuro and immune modulator on the brain is an innovative and 
relatively new area of study, there are few direct-link studies on 
how the supplementation of vitamin D may reduce instances of 
major depressive disorder and suicide risk. Vitamin D supple-
mentation treatment for major depressive disorder should be 
tested in a larger sample size, in patients with clinically sufficient 
vitamin D status, and for longer periods of time. Additionally, this 
treatment should be tested in patients with suicidal ideation, as 
this is the subgroup that has been differentiated to be effect-
ed most by vitamin D deficiency. Furthermore, studies should 
assess the difference between treatments that raise vitamin D 
levels by intake versus UV ray exposure. Perhaps, vitamin D sta-
tus and its effects may differ when synthesized naturally in the 
skin with direct access to subcutaneous fat for storage and the 
bloodstream, in contrast the supplementation being first pro-
cessed in the gastrointestinal tract. Vitamin D as a treatment 
method for major depressive disorder is a new and exciting area 
of research that may impact the global population tremendous-
ly due to the large number of people suffering of depression 
worldwide. More research on the effectiveness and limitations 
of this treatment should be done to maximize its impact.
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